Insulin Glargine "All to Target" Trial

Clinical trial NCT00384085 · COMPLETED

Trial details

NCT number: NCT00384085
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-05-01
Primary completion: 2010-03-01
Enrollment: 588

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.